← Back to Patent Explorer
US4103019A Expired / Lapsed US ⏱️ 0.0 years remaining

Triterpene derivatives

Assignee: Laboratorios Landerlan SA
•
Filing: 1975-10-07
•
Granted: 1978-07-25
•
Expires: 1995-10-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Glycyrrhetinic acid esters of the formula: ##STR1## wherein R is hydrogen or an acyl radical of 2 to 20 carbon atoms and R 1 is a lower alkyl of 1 to 4 carbon atoms and the haloacid or alkylsulfate quaternary ammonium salts thereof as well as a process for preparing same are provided. The compounds of the invention display anti-inflammatory, antihistaminic, and anti-ulcer pharmacological activity.

Inventors

  • 👤 Jose E. Acosta Mira

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 23:23
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/04; C07D207/08

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 28 words
Compounds of the formula ##STR7## wherein R is hydrogen or a carboxylic acyl group of 2 to 20 carbon atoms and R 1 is a lower alkyl group.
Claim 2
Dependent Claim 28 words
Compounds of the formula ##STR7## wherein R is hydrogen or a carboxylic acyl group of 2 to 20 carbon atoms and R 1 is a lower alkyl group.
Claim 3
Dependent Claim 41 words
Compounds of the formula ##STR8## wherein R is hydrogen or a carboxylic acyl group of 2 to 20 carbon atoms, R 1 and R 2 are lower alkyl of 1 to 4 carbon atoms and Y is a pharmaceutically acceptable anion.
Claim 4
Dependent Claim 41 words
Compounds of the formula ##STR8## wherein R is hydrogen or a carboxylic acyl group of 2 to 20 carbon atoms, R 1 and R 2 are lower alkyl of 1 to 4 carbon atoms and Y is a pharmaceutically acceptable anion.
Claim 5
Dependent Claim 9 words
The compound of claim 1 having the formula ##STR9##
Claim 6
Dependent Claim 9 words
The compound of claim 2 consisting of 2(glycyrrhetinoylmethyl)N-methylpyrrolidine methylsulfate.
Claim 7
Dependent Claim 9 words
The compound of claim 2 consisting of 2(glycyrrhetinoylmethyl)N-methylpyrrolidine methylbromide.
Claim 8
Dependent Claim 19 words
A process for treating gastroduodenal ulcers comprising administering a therapeutically effective amount of the compound defined by claim 1.
Claim 9
Dependent Claim 19 words
A process for treating gastroduodenal ulcers comprising administering a therapeutically effective amount of the compound defined by claim 2.
Claim 10
Dependent Claim 20 words
The process as defined by claim 6, wherein the amount of compound administered is between about 2 and 50 mg./Kg.
Claim 11
Dependent Claim 20 words
The process as defined by claim 6, wherein the amount of compound administered is between about 5 and 25 mg./Kg.
Claim 12
Dependent Claim 20 words
The process as defined by claim 7, wherein the amount of compound administered is between about 2 and 50 mg./Kg.
Claim 13
Dependent Claim 20 words
The process as defined by claim 7, wherein the amount of compound administered is between about 5 and 25 mg./Kg.

References Cited (Backward Citations)

GB894265A Cited
GB1255098A Cited
US3869458A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-07-24 1982-01-23 1982-07-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-07-24 1986-01-23 1986-07-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-07-24 1990-01-23 1990-07-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag